Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy

Journal of Paediatrics and Child Health

Volumn 37, Issue 5, 2001, Pages 483-488

  Tyrrell, V J ^a   Ambler, G R ^a   Yeow, W H ^a   Cowell, C T ^a   Silink, M ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Diazoxide; Hyperinsulinism; Hypoglycaemia; Nesidioblastosis

Indexed keywords

DIAZOXIDE; DIURETIC AGENT; GLUCAGON; GLUCOCORTICOID; GROWTH HORMONE; SOMATOSTATIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; FLUID RETENTION; GESTATIONAL AGE; HIGH BIRTH WEIGHT; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPOGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LIFE; MALE; PANCREAS RESECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIAZOXIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INFANT; INFANT, NEWBORN; INSULIN; MALE; PANCREATECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034772757     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00748.x     Document Type: Article

References (40)

1. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus
2. Persistent neonatal hyperinsulinism
3. Nesidioblastosis of the pancreas: Definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia
4. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycaemia of infancy
5. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycaemia of infancy
6. Edema associated with improved glycemic control in an adolescent with type 1 diabetes
7. Familial persistent hyperinsulinemic hypoglycaemia of infancy and mutations in the sulfonylurea receptor
8. ATP: An inward rectifier subunit plus the sulfonylurea receptor
9. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycaemia of infancy, not linked to the sulfonylurea receptor locus
10. Familial hyperinsulinism caused by an activating glucokinase mutation
11. Familial hyperinsulinism with apparent autosomal dominant inheritance. Clinical and genetic differences from the autosomal recessive variant
12. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
13. Persistent hyperinsulinemic hypoglycaemia of infancy: Experience with 28 cases
14. Persistent hyperinsulinaemic hypoglycaemia of infancy: Therapy, clinical outcome and mutational analysis
15. A case of familial nesidioblastosis: Prenatal diagnosis of foetal hyperinsulinism
16. Approach to the diagnosis of hyperglycaemai in infants and children
17. Therapy for persistent hyperinsulinemic hypoglycaemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin
18. Long-term treatment with diazoxide in childhood hyperinsulinism
19. Complications of diazoxide treatment in persistent neonatal hyperinsulinism
20. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
21. Persistent hyperinsulinemic hypoglycaemia of infancy: Long-term octreotide treatment without pancreatectomy
22. Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade
23. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycaemia of infancy
24. Successful conservative treatment of congenital hyperinsulinism (nesidioblastosis) with a combination of subcutaneous octreotide and nifedipine
25. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine
26. Neonatal and infantile hypoglycaemia due to insulin excess: New aspects of diagnosis and surgical management
27. Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood
28. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycaemia of the neonate?
29. Congenital hyperinsulinism and the surgeon: Lessons learned over 35 years
30. Role of initial near total (95%) pancreatectomy in persistent neonatal hyperinsulinism (PNH)
31. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: The pathologist's role
32. Clinical features of 52 neonates with hyperinsulinism
33. Persistent hyperinsulinemic hypoglycaemia of infancy: Long-term outcome following subtotal pancreatectomy
34. Surgical management of hyperinsulinemic hypoglycaemia in children
35. Growth and endocrine function after near total pancreatectomy for hyperinsulinaemic hypoglycaemia
36. Hyperinsulinemic hypoglycaemia of infancy (nesidioblastosis) in clinical remission: High incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up
37. Hyperinsulinism in infants and children
38. + channels